How many investments has Harmonix Fund made?

Harmonix Fund has 36 tracked investments.

What stage does Harmonix Fund invest at?

Harmonix Fund invests at the Pre-Seed, Seed, Series A, Late Stage stages.

Where is Harmonix Fund located?

Harmonix Fund is headquartered in La Quinta, US.

Who does Harmonix Fund co-invest with?

Harmonix Fund most often shares deals with Bold Capital Partners, DCVC (Data Collective), Lux Capital, among 78 tracked co-investors.

Harmonix Fund

Venture capital

La Quinta · Pre-Seed–Late Stage · 6 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Harmonix invests at the early stage in companies working to advance human health and improve quality of life through meaningful innovation. It partners with founders building in healthcare, life sciences, and deep tech, backing pioneering technologies aimed at transformative change. Its multidisciplinary team of entrepreneurs, scientists, operators, and industry experts offers technical, operating, industry, and advisory support to help companies accelerate and commercialize the next generation of technological advances. Investment decisions are guided by an evidence-based due diligence framework used to assess prospective companies.

Invests inBiotech Deep Tech Digital Health Healthtech Longevity Medical Devices

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Late Stage

La Quinta, US

Founded

2020

Tracked investments

Team · 6 people

from the firm's website

Cofield Mundi· Partner· Californiain

Cofield Mundi is Chief Operating Officer and partner at Harmonix, providing strategic support to the fund and its 40+ companies. She has over 30 years of experience in operational and business leadership roles across verticals including interior lifestyle brands, import/export, and entertainment, having led teams of up to 45 people. She grew up in South Africa and has lived in Botswana, Kenya, London, and the United States, and is also a recording artist previously signed to Sony and Universal Music.

Maximilian Winter· General Partner· United Statesin

Maximilian Winter is a fourth-generation entrepreneur from a German family business with over 70 years of history, and has experience running a family enterprise, family office, and philanthropic foundation. At Harmonix, he focuses on investing in scalable scientific breakthroughs, with particular interest in transforming healthcare and advancing human health and infrastructure through technology.

Dave Messina· Advisor· San Diego, California, United Statesin 𝕏

Dave Messina is General Partner of Pioneer Fund's Future of Health Fund, which invests in Y Combinator healthtech companies and is comprised of over 100 Y Combinator alumni. He has led more than 100 healthcare investments since joining Pioneer Fund in 2019, including exits and companies such as Gilgamesh, Assort Health, Stepful, Freshpaint, and PostEra. Prior to venture capital, Messina founded Cofactor Genomics, an RNA and machine learning company that obtained Medicare reimbursement, and has over 25 years of experience in healthcare that includes work on the Human Genome Project and a PhD in computational biology.

Erez Podoly· Advisor· Israelin

Erez Podoly is Director of IT and Security at RealSense with over twenty years of experience in IT infrastructure and security strategy across global organisations. He has led cross-functional teams across multiple regions, managing large-scale infrastructure programs, enterprise system implementations, and M&A integration efforts. His work spans cybersecurity, governance and risk compliance, cloud and endpoint security, and digital transformation initiatives.

Michael Fenn· Advisor· Milan, Lombardy, Italyin

Michael Fenn is Director of External Innovation at Dewpoint Therapeutics and previously served as Director of Healthcare & Life Sciences at Harvard Innovation Labs, where he co-led planning of Life Lab Longwood at Harvard Medical School. He was formerly an Assistant Professor of Biomedical Engineering and Director of the Center for Medical Materials & Biophotonics at the Florida Institute of Technology. He holds a Ph.D. in Biomedical Engineering, an M.S. in Materials Science and Engineering, and a B.S. in Chemistry/Biochemistry, all from the University of Florida, and has cofounded and advised multiple startups.

Paul McEwan· Advisor· Pleasanton, California, United Statesin

Paul McEwan has more than 25 years of experience in the life science tools sector as both an entrepreneur and investor, beginning his career developing technology for the Human Genome Project at the Whitehead Institute Center for Genome Research. He co-founded several life science tools companies, including Agencourt Bioscience, Agencourt Personal Genomics, and Kapa Biosystems, which together reached a combined exit value of $700M. As an angel investor he has made over 20 investments in life science startups.

What they invest in

from 13 of 36 portfolio companies

AI & Machine Learning ×9Healthtech ×8Biotech ×6Medical Devices ×5Digital Health ×2Enterprise Software ×2Hardware ×2AgTech ×1

HQs:United States×11

Investments · 36 tracked

founders shown can be your intro path

By year:2019 · 1 2018 · 12 dated

Abalone Bio

Aether

Ancilia Therapeutics

Atlas

Attivare

Auransaauransa.com in

Auransa is a clinical-stage biopharmaceutical company that uses an AI platform to analyze large-scale human disease datasets and gene expression profiles to discover novel cancer therapeutics.

AI & Machine LearningBiotechHealthtech

Pek Lum(Co-Founder and CEO)

Co-investors11.2 Capital DCVC (Data Collective)Lux Capital

Babylon Microfarms

Bioz

Caresyntaxcaresyntax.comNov 2019

HealthtechBoston, US

Bjoern von Siemens(Executive Officer, Director)Dennis Kogan(Executive Officer, Director)Filip Pintelon(Director)Werner Zoellner(Director)Paul Summerside(Director)Timothy Lantz(Executive Officer)

Co-investorsIntel Capital Lauxera Capital Partners Optum Ventures

Dermasensor

GEn1E Lifesciencesgen1e.com in 𝕏

Gen1e builds healthcare solutions supported by a network of physicians across hospitals and medical centers.

AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US

Ritu Lal(Founder)inSoujanya Bhumkar(Executive Officer, Director)

BoardNoor Kamruddin(Director)Francois Nader(Director)Alan Levy(Director)

Co-investorsClear Ventures Y Combinator Khosla Ventures Inflect Health

Halo Industries

Insilico Medicineboldcapitalpartners.com in 𝕏

This page is a thought-leadership essay by Teymour Boutros-Ghali of Bold Capital Partners arguing that venture investors and foundations should fund the commercialization phase of health-equity-focused life science companies using non-dilutive capital.

BiotechBaltimore, US

Aleksandrs Zavoronkovs(Executive Officer, Director)

Co-investorsB Capital Group Bold Capital Partners BOLD Longevity LongeVC SquareOne Capital

Juvena Therapeuticsjuvenatherapeutics.com in

Juvena Therapeutics develops biologics derived from human secreted proteins to treat aging-related diseases, using AI-enabled drug discovery to identify tissue-restorative therapeutics for muscle and metabolic disorders.

AI & Machine LearningBiotechLongevityMedical DevicesRedwood City, US

Jeremy O'Connell, PhD(Chief Scientific Officer and Co-Founder)Hanadie Yousef, PhD(Executive Advisor and Co-Founder)Hanadie Yousef(Executive Officer, Director)Jeremy O'Connell(Director)

BoardBen Hemani(Director)inLaura Lande-Diner(Director)in

Co-investorsBascom Ventures Bison Ventures Compound Horizons Ventures Manta Ray Ventures Open Field Capital +3 more

Loft Orbitalloftorbital.com in 𝕏

Loft Orbital operates space infrastructure, providing satellites equipped with sensing resources, onboard edge compute, and connectivity that let customers run missions without deploying their own hardware.

AI & Machine LearningDeep TechDefense TechHardwareSpace TechSan Francisco, US

Pierre-Damien Vaujour(Founder)inAlex Greenberg(Founder)in

Co-investors1809 Capital Blitzscaling Ventures Chaos Ventures EQUIAM Flucas Ventures Kima Ventures +15 more

Nelumbo

Paradromics

Develops next-generation brain-computer interfaces offering high data rate connections between brains and computers for medical applications.

Austin, US

Co-investorsAlpha Edison Capital Factory Fusion Hartmann Capital IT-Farm Corporation Prevail Venture Capital+4 more

Pathology Watchpathologywatch.com

A digital pathology platform that digitizes histologic slides and distributes workload to expert dermatopathologists for remote consultation and skin cancer diagnosis.

Salt Lake City, US

Daniel Lambert(Executive Officer, Director)Yiannis Monovoukas(Director)Gregory Osmond(Executive Officer, Director)Michael Torno(Executive Officer, Director)

BoardRick Stratford(Director)

Co-investorsBeni Venture Capital Rock Creek Capital SpringTide Ventures

PolySpectra

Pragma Bio

Precipointprecipoint.com

PreciPoint develops digital microscopy systems, including a live digital microscope for rapid on-site sample evaluation.

HardwareHealthtechMedical Devices

Qu Biologicsqubiologics.com in 𝕏May 2018

Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function.

BiotechHealthtechBurnaby

Harold David Gunn(Executive Officer, Director)Simon Sutcliffe(Chief Medical Officer)Alun Rees(Executive Officer)Robert E. Pelzer(Director)Michael Leschuk(Director)Gillian Vandermeirsch(Executive Officer)

Co-investorsCuritas Ventures

Rad AIradai.com in 𝕏

Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows.

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSan Francisco, US

Dr. Jeff Chang(Co-founder)inDoktor Gurson(Co-founder)in

BoardStuart Peterson(Director)inBruce Armstrong(Director)in

Co-investorsArray Ventures Management Llc Artis Ventures City Light Corewell Health Ventures Fifty Years GMO VenturePartners +8 more

Sana health

SentiAR

Sorcerosorcero.com in 𝕏

Sorcero develops AI-powered intelligence solutions for the life sciences industry, helping companies accelerate patient access to therapies and improve medical research and communications.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMedical DevicesWashington, US

Dipanwita Das(CEO and Co-founder)Richard Graves(Executive Officer, Director)Walter Bender(CTO)Claiborne P. Deming(Director)

BoardOliver Libby(Director)Peter Hart Callahan(Director)

Co-investorsJanuary Ventures Mighty Capital NZVC Rackhouse Venture Management Lp WorldQuant Ventures Leawood Venture Capital Llc +1 more

spotlight-image

Strateosstrateos.com in 𝕏

Strateos operates a cloud lab platform offering high-throughput laboratory automation as a service, letting scientists design, run, and analyze experiments remotely through a web browser.

AI & Machine LearningBiotechRobotics

Co-investorsDCVC (Data Collective)Lux Capital Dolby Family Ventures OS Fund Silicon Badia

Tarana

Terrameraterramera.com in 𝕏

Terramera develops technology for clean food, combining its proprietary Actigate Targeted Performance platform with data science and machine learning to reduce synthetic chemical loads and create natural agricultural products for farmers and consumers.

AgTechAI & Machine LearningClimate TechVancouver

Michael Scott(Executive Officer)Karn Manhas(Executive Officer, Director)Alex Lau(Director)Jeffrey Booth(Director)Craig Hughes(Executive Officer)

BoardSanjeev Krishnan(Director)

Co-investorsArcTern Ventures Bold Capital Partners Ospraie Ag Science S2G Investments Renewal Funds

Trials AI

Unlimited Tomorrow

Rhinebeck, US

Easton LaChappelle(Executive Officer, Director, Promoter)Allen Morgan(Director)

BoardDakin Sloss(Director)in

Co-investorsPrime Movers Lab

Viscient Biosciences

Visicell

Volumetric

xCuresxcures.com in

xCures builds an AI platform that assembles and structures fragmented medical records into organized, decision-ready clinical data for healthcare organizations.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechOakland, US

Mika Newton(Chief Executive Officer)Glenn Kramer(Chief Technology Officer)Kenny Wong(Chief Product Officer)

Co-investorsCivilization Ventures Management, Llc Healthtech Capital Innovius Capital Lauder Partners Metaplanet Portfolia +4 more

Portfolio news

latest coverage across their companies

Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths | The Manila Times

Insilico Medicine · manilatimes.net · Aug 17, 2026

Nykaa Stock And 2 Fast Growth Picks With High Insider Ownership - Simply Wall St News

GEn1E Lifesciences · simplywall.st · Jul 16, 2026

Regenerative Medicine Startup Funding (2026) – New Market Pitch

Juvena Therapeutics · newmarketpitch.com · Jul 13, 2026

xCures Closes $46 Million Series B Financing | Cadence Raises $100M Series C Led by Spark Capital | Healthcare IT Today

xCures · healthcareittoday.com · Jul 10, 2026

Sorcero Raises $42.5M in Series B Funding

Sorcero · finsmes.com · Nov 24, 2025

Rad AI Raises Additional $8M in Funding

Rad AI · finsmes.com · May 20, 2025

Sell or Invest in Loft Orbital Stock Pre-IPO

Loft Orbital · nasdaqprivatemarket.com · Mar 2, 2025

Frequently asked questions

How many investments has Harmonix Fund made?: Harmonix Fund has 36 tracked investments.
What stage does Harmonix Fund invest at?: Harmonix Fund invests at the Pre-Seed, Seed, Series A, Late Stage stages.
What sectors does Harmonix Fund focus on?: Harmonix Fund focuses on Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices.
Where is Harmonix Fund located?: Harmonix Fund is headquartered in La Quinta, US.
Who does Harmonix Fund co-invest with?: Harmonix Fund most often shares deals with Bold Capital Partners, DCVC (Data Collective), Lux Capital, among 78 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Maximilian Winter shares the mission at Harmonix Fund #deeptech #lifescience #healthcare #innovation

VC10X with Prashant Choubey · Maximilian Winter

Science - Driven VC Fund, Maximilian Winter, GP & Krish Ramadurai, Partner at Harmonix fund

VC10X with Prashant Choubey · Maximilian Winter

Images

Co-investors · 11

Flucas Ventures

Flucas Ventures is a solo GP fund led by Ashley Flucas, who simultaneously serves as COO of Summit Ventures while personally investing in 250-275+ startups and deploying over $75M through a syndicate of 2,000+ LPs in less than two years. The fund operates with true stage, sector, and geography agnosticism while democratizing access to top-tier venture deals by inviting diverse, nontraditional LPs to co-invest alongside marquee firms like Sequoia and Andreessen Horowitz.

Both backed · 1

Loft Orbital

$100K – $5M

General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

$30M

Alumni Ventures

Alumni Ventures (AV) is a venture firm that gives accredited individual investors access to professionally managed, diversified venture portfolios by co-investing alongside leading lead VC firms. It offers annual funds, syndicate deal-by-deal investing, and various investor clubs.

$100K – $10M

SoftBank Vision Fund

SoftBank Vision Fund invests globally in AI-focused companies working to transform and create industries.

Amplify Partners

Amplify Partners is a venture capital firm that backs founders who are engineers, researchers, and scientists building technical companies.

$500K – $5M

Wing

Wing is a venture capital firm that invests in early-stage companies focused on business technology, data, mobile, and cloud infrastructure. The firm was founded by two experienced investors who maintain long-term engagement with their portfolio companies.

$200K – $20M

Entrepreneur First

Entrepreneur First (EF) is a talent investor that helps individuals build and launch startups, providing support such as US visa guidance, office space, fundraising preparation, and investor introductions culminating in a San Francisco Demo Day.

$1M – $7M

Montage Ventures

Montage Ventures is a venture capital firm investing in startups across financial services, healthcare, and commerce, with a focus on AI-driven transformation of these sectors.

$4M

ANIMO Ventures

ANIMO is a venture capital firm founded by Nico Berardi, a seasoned early-stage investor with experience in Latin America and the broader startup ecosystem.

$500K – $2M

Esplanade Ventures

Canada's leading digital health venture capital firm investing in early-stage and high-growth technology companies transforming healthcare delivery across North America. The firm provides capital alongside hands-on operational guidance, commercial introductions, and go-to-market strategy support.

Vistara Growth

Vistara Growth is a technology-focused financing firm that partners with growth-stage companies, providing capital as both a lender and an equity partner.

Firms observed investing alongside Harmonix Fund, from public investor directories. Shared companies are the overlap with Harmonix Fund's recorded portfolio.

Similar investors

Khosla Ventures

Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.

$5K – $50M

Pontifax Venture Capital

Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.

$6.3M – $128M

Sofinnova Partners

Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.

$540K – $27M

Basecamp Fund

A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.

$100K – $10M

Seido Capital

Seido Capital is a North American venture capital firm investing in life sciences and deep tech companies from pre-seed to IPO, building on the legacy of the Belgian Theodorus funds.

$270K – $2.7M